← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2010Last known activity
Feb 1, 2025
Timeline
2000s
- Sep 1, 2007
Stand Up To Cancer— Founded
Drugs by trial phase (51 distinct, 36 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (35 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anus Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Adenosquamous
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Cystadenocarcinoma, Serous
- Head and Neck Neoplasms
- Lung Neoplasms
- Melanoma
- Neoplasm, Residual
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Recurrence
- Sarcoma
- Skin Neoplasms
- Triple Negative Breast Neoplasms
- Uterine Cervical Neoplasms
Recent trials (36)
- NCT06707896CollaboratorPhase 1Feb 1, 2025
- NCT06208657CollaboratorPhase 1/Phase 2Jul 10, 2024
- NCT05918640CollaboratorPhase 1/Phase 2Jul 27, 2023
- NCT05212025CollaboratorPhase 2Jun 30, 2022
- NCT05013216CollaboratorPhase 1Dec 31, 2021
- NCT04995003CollaboratorPhase 1Dec 1, 2021
- NCT04524195CollaboratorPhase 1Feb 1, 2021
- NCT04469556CollaboratorPhase 2Oct 14, 2020
- NCT04434040CollaboratorPhase 2Jun 30, 2020
- NCT04261218CollaboratorPhase 1Feb 29, 2020
- NCT03697564CollaboratorPhase 2Sep 30, 2019
- NCT03936465CollaboratorPhase 1Jun 30, 2019
- NCT03697239CollaboratorPhase 1/Phase 2Jun 30, 2019
- NCT03908333CollaboratorPhase 1/Phase 2May 1, 2019
- NCT03803553CollaboratorPhase 3Feb 1, 2019
Details
- Founded
- Los Angeles, CA, US Sep 1, 2007
- Last known activity
- Feb 1, 2025